Company: AIBT
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001096906-25-001895
Chunk: 8

Company: AIBOTICS, INC.
Filing Date: 2025-11-19
Form: 10-Q
Item: Item 1
Chunk 8
---
ITEM 1. FINANCIAL STATEMENTS

AIBOTICS THERAPIES, INC

CONDENSED CONSOLIDATED BALANCE SHEETS

September 30,
 
December 31,

2025
 
2024

(unaudited)

ASSETS

CURRENT ASSETS:

Cash
 
$230,470  
 
$185,097  

Other receivable
 
10,926  
 
-  

Total Current Assets
 
241,396  
 
185,097  

NON-CURRENT ASSETS:

Intangible assets, net
 
775,547  
 
1,271,898  

TOTAL ASSETS
 
$1,016,943  
 
$1,456,995  

LIABILITIES AND STOCKHOLDERS’ DEFICIT

CURRENT LIABILITIES:

Accounts payable and accrued expenses
 
$481,845  
 
$283,341  

Accrued interest
 
179,710  
 
399,822  

Accrued expenses – related party
 
765,000  
 
864,000  

Convertible note payable, net of debt discount
 
1,315,417  
 
1,100,000  

Notes payable – related party
 
165,000  
 
165,000  

Shares to be issued
 
1,995,600  
 
2,039,600  

TOTAL LIABILITIES
 
4,902,572  
 
4,851,763  

Commitments and contingencies (Note 9 – Commitments and Contingencies)
 
-  
 
-  

MEZZANINE EQUITY

 Series B Preferred stock, $0.001 par value; 1,500,000 shares authorized at September 30, 2025 and December 31, 2024; 200 shares issued and outstanding as of September 30, 2025 and December 31, 2024; liquidation preference of $0 as of September 30, 2025 and December 31, 2024
 
200  
 
200  

STOCKHOLDERS’ DEFICIT

Preferred stock, 5,000,000 shares authorized:

Series A Preferred Stock, $0.001 par value, 0 shares authorized at September 30, 2025 and December 31, 2024; 0 shares issued and outstanding as of September